Efficacy and Safety of Nintedanib in Patients with Interstitial Lung Disease with or without Systemic Sclerosis: A Meta-Analysis
کلید واژگان
NintedanibEfficacy
Safety
Interstitial lung disease
شماره نشریه
9ناشر
Tehran, Tehran University of Medical Sciencesسازمان پدید آورنده
Department of Rheumatology, Korea University College of Medicine, Seoul, KoreaDepartment of Rheumatology, Korea University College of Medicine, Seoul, Korea
شاپا
2251-60852251-6093
